BioNTech SE (BNTX) Share-based Compensation (QoQ) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.99% |
| Sep 30, 2025 | -10.24% |
| Jun 30, 2025 | 56.31% |
| Mar 31, 2025 | -7.43% |
| Dec 31, 2024 | -44.09% |
| Sep 30, 2024 | 106.49% |
| Jun 30, 2024 | 22.85% |
| Mar 31, 2024 | 15.90% |
| Dec 31, 2023 | -9.45% |
| Sep 30, 2023 | 18.28% |
| Jun 30, 2023 | 54.54% |
| Mar 31, 2023 | -59.25% |
| Dec 31, 2022 | -63.41% |
| Sep 30, 2022 | 292.01% |
| Jun 30, 2022 | 25.63% |
| Mar 31, 2022 | -46.40% |
| Dec 31, 2021 | -68.13% |
| Sep 30, 2021 | 177.75% |
| Jun 30, 2021 | 126,960,404.02% |
| Mar 31, 2021 | 139.76% |
| Mar 31, 2020 | 8.59% |